title: De novo cancer after orthotopic liver transplantation.
authors.affiliation: Department of Digestive Surgery and Liver Transplantation, Croix-Rousse Hospital, Lyon, France.
authors.forename: V
authors.initials: V
authors.lastname: Peyrègne
authors.forename: C
authors.initials: C
authors.lastname: Ducerf
authors.forename: M
authors.initials: M
authors.lastname: Adham
authors.forename: E
authors.initials: E
authors.lastname: de la Roche
authors.forename: N
authors.initials: N
authors.lastname: Berthoux
authors.forename: B
authors.initials: B
authors.lastname: Bancel
authors.forename: T
authors.initials: T
authors.lastname: Bizollon
authors.forename: J
authors.initials: J
authors.lastname: Baulieux
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015994:Incidence; D016031:Liver Transplantation / Q000009:adverse effects* / Q000276:immunology / Q000401:mortality; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000145:classification / Q000453:epidemiology* / Q000401:mortality; D011183:Postoperative Complications; D012189:Retrospective Studies; D015996:Survival Rate; D013997:Time Factors
chemical_list: D007166:Immunosuppressive Agents